APO Research

APO RESEARCH · REPORT

Bifidus

Selected research

Market Structure

Global Bifidus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Bifidus market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma and Shandong Zhongke Jiayi Bioengineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bifidus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bifidus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bifidus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidus market size, projected growth trends, production technologies, key applications, and end-use industries.

Bifidus Segment by Company

Chr-Hansen

DuPont

Wecare Probiotics

Probi

Mitushi Bio Pharma

Scitop Bio-tech

Lallemand

Goerlich Pharma

Shandong Zhongke Jiayi Bioengineering

Danone

Shanghai SPH Sinopharm

Bifidus Segment by Type

Food Grade

Pharmaceutical Grade

Bifidus Segment by Application

Food & Beverages

Medicines

Health Products

Others

Bifidus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bifidus market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bifidus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bifidus Industry Trends Table 2. Bifidus Industry Drivers Table 3. Bifidus Industry Opportunities and Challenges Table 4. Bifidus Industry Restraints Table 5. Global Bifidus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bifidus Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bifidus Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Bifidus Sales Market Share by Manufacturers Table 9. Global Bifidus Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Bifidus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bifidus Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bifidus Manufacturers, Product Type & Application Table 13. Global Bifidus Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bifidus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Food Grade Table 17. Major Manufacturers of Pharmaceutical Grade Table 18. Global Bifidus Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Bifidus Sales by Type (2021-2026) & (k units) Table 20. Global Bifidus Sales by Type (2027-2032) & (k units) Table 21. Global Bifidus Sales Market Share by Type (2021-2026) Table 22. Global Bifidus Sales Market Share by Type (2027-2032) Table 23. Global Bifidus Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Bifidus Revenue by Type (2021-2026) & (k units) Table 25. Global Bifidus Revenue by Type (2027-2032) & (k units) Table 26. Global Bifidus Revenue Market Share by Type (2021-2026) Table 27. Global Bifidus Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Food & Beverages Table 29. Major Manufacturers of Medicines Table 30. Major Manufacturers of Health Products Table 31. Major Manufacturers of Others Table 32. Global Bifidus Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Bifidus Sales by Application (2021-2026) & (k units) Table 34. Global Bifidus Sales by Application (2027-2032) & (k units) Table 35. Global Bifidus Sales Market Share by Application (2021-2026) Table 36. Global Bifidus Sales Market Share by Application (2027-2032) Table 37. Global Bifidus Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Bifidus Revenue by Application (2021-2026) & (k units) Table 39. Global Bifidus Revenue by Application (2027-2032) & (k units) Table 40. Global Bifidus Revenue Market Share by Application (2021-2026) Table 41. Global Bifidus Revenue Market Share by Application (2027-2032) Table 42. Global Bifidus Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Bifidus Sales by Region (2021-2026) & (k units) Table 44. Global Bifidus Sales Market Share by Region (2021-2026) Table 45. Global Bifidus Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Bifidus Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Bifidus Sales by Country (2021-2026) & (k units) Table 49. North America Bifidus Sales by Country (2027-2032) & (k units) Table 50. Europe Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Bifidus Sales by Country (2021-2026) & (k units) Table 52. Europe Bifidus Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Bifidus Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Bifidus Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Bifidus Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Bifidus Sales by Country (2027-2032) & (k units) Table 59. Global Bifidus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Bifidus Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Bifidus Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Bifidus Revenue Market Share by Region (2021-2026) Table 63. Global Bifidus Revenue Market Share by Region (2027-2032) Table 64. Chr-Hansen Company Information Table 65. Chr-Hansen Business Overview Table 66. Chr-Hansen Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chr-Hansen Bifidus Product Portfolio Table 68. Chr-Hansen Recent Development Table 69. DuPont Company Information Table 70. DuPont Business Overview Table 71. DuPont Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. DuPont Bifidus Product Portfolio Table 73. DuPont Recent Development Table 74. Wecare Probiotics Company Information Table 75. Wecare Probiotics Business Overview Table 76. Wecare Probiotics Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Wecare Probiotics Bifidus Product Portfolio Table 78. Wecare Probiotics Recent Development Table 79. Probi Company Information Table 80. Probi Business Overview Table 81. Probi Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Probi Bifidus Product Portfolio Table 83. Probi Recent Development Table 84. Mitushi Bio Pharma Company Information Table 85. Mitushi Bio Pharma Business Overview Table 86. Mitushi Bio Pharma Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Mitushi Bio Pharma Bifidus Product Portfolio Table 88. Mitushi Bio Pharma Recent Development Table 89. Scitop Bio-tech Company Information Table 90. Scitop Bio-tech Business Overview Table 91. Scitop Bio-tech Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Scitop Bio-tech Bifidus Product Portfolio Table 93. Scitop Bio-tech Recent Development Table 94. Lallemand Company Information Table 95. Lallemand Business Overview Table 96. Lallemand Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Lallemand Bifidus Product Portfolio Table 98. Lallemand Recent Development Table 99. Goerlich Pharma Company Information Table 100. Goerlich Pharma Business Overview Table 101. Goerlich Pharma Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Goerlich Pharma Bifidus Product Portfolio Table 103. Goerlich Pharma Recent Development Table 104. Shandong Zhongke Jiayi Bioengineering Company Information Table 105. Shandong Zhongke Jiayi Bioengineering Business Overview Table 106. Shandong Zhongke Jiayi Bioengineering Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio Table 108. Shandong Zhongke Jiayi Bioengineering Recent Development Table 109. Danone Company Information Table 110. Danone Business Overview Table 111. Danone Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Danone Bifidus Product Portfolio Table 113. Danone Recent Development Table 114. Shanghai SPH Sinopharm Company Information Table 115. Shanghai SPH Sinopharm Business Overview Table 116. Shanghai SPH Sinopharm Bifidus Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Shanghai SPH Sinopharm Bifidus Product Portfolio Table 118. Shanghai SPH Sinopharm Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Bifidus Distributors List Table 122. Bifidus Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Bifidus Product Image Figure 2. Global Bifidus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidus Market Size (2021-2032) & (US$ Million) Figure 4. Global Bifidus Sales (2021-2032) & (k units) Figure 5. Global Bifidus Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bifidus Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Food Grade Image Figure 9. Pharmaceutical Grade Image Figure 10. Global Bifidus Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Bifidus Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bifidus Sales Market Share by Type (2021-2032) Figure 13. Global Bifidus Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Bifidus Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bifidus Revenue Market Share by Type (2021-2032) Figure 16. Food & Beverages Image Figure 17. Medicines Image Figure 18. Health Products Image Figure 19. Others Image Figure 20. Global Bifidus Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Bifidus Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Bifidus Sales Market Share by Application (2021-2032) Figure 23. Global Bifidus Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Bifidus Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Bifidus Revenue Market Share by Application (2021-2032) Figure 26. North America Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Bifidus Sales Market Share by Country (2021-2032) Figure 28. U.S. Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Bifidus Sales Market Share by Country (2021-2032) Figure 33. Germany Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Bifidus Sales Market Share by Country (2021-2032) Figure 40. China Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Bifidus Sales Market Share by Country (2021-2032) Figure 48. Brazil Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Bifidus Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Bifidus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Bifidus Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Bifidus Revenue (2021-2032) & (US$ Million) Figure 59. North America Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Bifidus Revenue (2021-2032) & (US$ Million) Figure 61. Europe Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Bifidus Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Bifidus Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Bifidus Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Bifidus Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Pharmaceutical Grade
Applications
  • Food & Beverages
  • Medicines
  • Health Products
  • Others
Companies covered
  • Chr-Hansen
  • DuPont
  • Wecare Probiotics
  • Probi
  • Mitushi Bio Pharma
  • Scitop Bio-tech
  • Lallemand
  • Goerlich Pharma
  • Shandong Zhongke Jiayi Bioengineering
  • Danone
  • Shanghai SPH Sinopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bifidus Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bifidus Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bifidus Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bifidus Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bifidus Market Dynamics
  1. 2.1 Bifidus Industry Trends
  2. 2.2 Bifidus Industry Drivers
  3. 2.3 Bifidus Industry Opportunities and Challenges
  4. 2.4 Bifidus Industry Restraints
3 Bifidus Market by Manufacturers
  1. 3.1 Global Bifidus Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bifidus Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bifidus Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bifidus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bifidus Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bifidus Manufacturers, Product Type & Application
  7. 3.7 Global Bifidus Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bifidus Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bifidus Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bifidus Tier 1, Tier 2, and Tier 3
4 Bifidus Market by Type
  1. 4.1 Bifidus Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Pharmaceutical Grade
  4. 4.2 Global Bifidus Sales by Type
  5. 4.2.1 Global Bifidus Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bifidus Sales by Type (2021-2032)
  7. 4.2.3 Global Bifidus Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bifidus Revenue by Type
  9. 4.3.1 Global Bifidus Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bifidus Revenue by Type (2021-2032)
  11. 4.3.3 Global Bifidus Revenue Market Share by Type (2021-2032)
5 Bifidus Market by Application
  1. 5.1 Bifidus Application Introduction
  2. 5.1.1 Food & Beverages
  3. 5.1.2 Medicines
  4. 5.1.3 Health Products
  5. 5.1.4 Others
  6. 5.2 Global Bifidus Sales by Application
  7. 5.2.1 Global Bifidus Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bifidus Sales by Application (2021-2032)
  9. 5.2.3 Global Bifidus Sales Market Share by Application (2021-2032)
  10. 5.3 Global Bifidus Revenue by Application
  11. 5.3.1 Global Bifidus Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bifidus Revenue by Application (2021-2032)
  13. 5.3.3 Global Bifidus Revenue Market Share by Application (2021-2032)
6 Global Bifidus Sales by Region
  1. 6.1 Global Bifidus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bifidus Sales by Region (2021-2032)
  3. 6.2.1 Global Bifidus Sales by Region (2021-2026)
  4. 6.2.2 Global Bifidus Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bifidus Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bifidus Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bifidus Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bifidus Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bifidus Revenue by Region
  1. 7.1 Global Bifidus Revenue by Region
  2. 7.1.1 Global Bifidus Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bifidus Revenue by Region (2021-2026)
  4. 7.1.3 Global Bifidus Revenue by Region (2027-2032)
  5. 7.1.4 Global Bifidus Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bifidus Revenue (2021-2032)
  8. 7.2.2 North America Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bifidus Revenue (2021-2032)
  11. 7.3.2 Europe Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bifidus Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bifidus Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chr-Hansen
  2. 8.1.1 Chr-Hansen Company Information
  3. 8.1.2 Chr-Hansen Business Overview
  4. 8.1.3 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chr-Hansen Bifidus Product Portfolio
  6. 8.1.5 Chr-Hansen Recent Developments
  7. 8.2 DuPont
  8. 8.2.1 DuPont Company Information
  9. 8.2.2 DuPont Business Overview
  10. 8.2.3 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DuPont Bifidus Product Portfolio
  12. 8.2.5 DuPont Recent Developments
  13. 8.3 Wecare Probiotics
  14. 8.3.1 Wecare Probiotics Company Information
  15. 8.3.2 Wecare Probiotics Business Overview
  16. 8.3.3 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wecare Probiotics Bifidus Product Portfolio
  18. 8.3.5 Wecare Probiotics Recent Developments
  19. 8.4 Probi
  20. 8.4.1 Probi Company Information
  21. 8.4.2 Probi Business Overview
  22. 8.4.3 Probi Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Probi Bifidus Product Portfolio
  24. 8.4.5 Probi Recent Developments
  25. 8.5 Mitushi Bio Pharma
  26. 8.5.1 Mitushi Bio Pharma Company Information
  27. 8.5.2 Mitushi Bio Pharma Business Overview
  28. 8.5.3 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
  30. 8.5.5 Mitushi Bio Pharma Recent Developments
  31. 8.6 Scitop Bio-tech
  32. 8.6.1 Scitop Bio-tech Company Information
  33. 8.6.2 Scitop Bio-tech Business Overview
  34. 8.6.3 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Scitop Bio-tech Bifidus Product Portfolio
  36. 8.6.5 Scitop Bio-tech Recent Developments
  37. 8.7 Lallemand
  38. 8.7.1 Lallemand Company Information
  39. 8.7.2 Lallemand Business Overview
  40. 8.7.3 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lallemand Bifidus Product Portfolio
  42. 8.7.5 Lallemand Recent Developments
  43. 8.8 Goerlich Pharma
  44. 8.8.1 Goerlich Pharma Company Information
  45. 8.8.2 Goerlich Pharma Business Overview
  46. 8.8.3 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Goerlich Pharma Bifidus Product Portfolio
  48. 8.8.5 Goerlich Pharma Recent Developments
  49. 8.9 Shandong Zhongke Jiayi Bioengineering
  50. 8.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
  51. 8.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
  52. 8.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
  54. 8.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
  55. 8.10 Danone
  56. 8.10.1 Danone Company Information
  57. 8.10.2 Danone Business Overview
  58. 8.10.3 Danone Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Danone Bifidus Product Portfolio
  60. 8.10.5 Danone Recent Developments
  61. 8.11 Shanghai SPH Sinopharm
  62. 8.11.1 Shanghai SPH Sinopharm Company Information
  63. 8.11.2 Shanghai SPH Sinopharm Business Overview
  64. 8.11.3 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
  66. 8.11.5 Shanghai SPH Sinopharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bifidus Value Chain Analysis
  2. 9.1.1 Bifidus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bifidus Production Mode & Process
  6. 9.2 Bifidus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bifidus Distributors
  9. 9.2.3 Bifidus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research